Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
CPIXCumberland Pharmaceuticals Inc
Filed Aug 8, 2011 · 10-Q · 39 days after period end · 0000950123-11-074496
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $14.39M | $10.74M |
| Net Income | $2.18M | $287.30K |
| EPS Diluted | $0.11 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 8, 2011 · 39 d after period end
